Themis Medicare Board approves results, appoints directors, fixes record date.
The board changes and financial results have a moderate impact on the company. Withdrawal of amalgamation scheme may have long term impact.
The announcement includes both positive elements like appointments and negative elements like a loss in the financial results and withdrawal of the amalgamation scheme, making the overall sentiment neutral.
* Approved Un-Audited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2025. * Appointed Ms. Neha Thakore as an Additional Non-Executive Woman Independent Director for 5 years w.e.f. 1st August, 2025, subject to shareholder approval. * Appointed Mr. Viraj Save as Executive President — Sales & Marketing w.e.f. 1st August, 2025. * Fixed the record date as 5th September, 2025, for final dividend entitlement for FY ended 31st March, 2025. * Consolidated revenue from operations (net) is ₹9,757.17 Lakhs * Standalone revenue from operations (net) is ₹9,757.77 Lakhs * The Board has also resolved to withdraw the Scheme of Amalgamation with Gujarat Themis Biosyn Limited (GTBL). * The company has received an approval for struck off M/s. Carpo Medicals Limited (UK), a wholly owned subsidiary company. The company has provided for Investment ₹0.76 lakhs and Receivable and advances amounting to ₹128.63 Lakhs in the Financial Statement
What to do with a filing like this
Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.